Scottish ProStrakan, JapanBridge Ink Sancuso Licensing Deal For Japan, China, And Southeast Asia
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Scotland-based ProStrakan Group has granted JapanBridge K.K. an exclusive license to develop and commercialize antiemetic Sancuso (granisetron) in Japan, mainland China, Taiwan, Singapore and Malaysia, the companies announced May 23